Breaking News

PAREXEL to Acquire Health Advances

Expands strategic portfolio- and product-level commercialization consulting

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

PAREXEL has entered into a definitive agreement to acquire all outstanding equity of Health Advances, LLC, a consulting firm that combines clinical, scientific and business expertise to provide strategic advice to life sciences companies. The acquisition is expected to close in February, subject to customary closing conditions. Health Advances employs approximately 120 scientists, clinicians, and business professionals in three main offices – two in the U.S. and one in Europe. It offers servi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters